Psychologic treatment of substance abuse

Current Opinion in Psychiatry

Volumn 11, Issue 3, 1998, Pages 289-293

  Grabowski, John ^a   Schmitz, Joy M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLISM; BEHAVIOR THERAPY; COGNITIVE THERAPY; DRUG DEPENDENCE; HUMAN; SHORT SURVEY; SUBSTANCE ABUSE;

EID: 0031944362     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-199805000-00009     Document Type: Short Survey

References (25)

1. NIH Consensus Report. Treatment of heroin addiction. Bethesda: NIH Office of Medical Applications of Research; 1997.
2. Marlatt GA, Gordon JR (editors). Relapse Prevention. New York: Guildford Press: 1985.
3. Longabaugh R, Rubin A, Stout RL, Zywiak WH, Lowman C. The reliability of Marlatt's taxonomy for classifying relapses. Addiction 1996; 91 (suppl):S73-S88.
4. Maisto SA, Connors GJ, Zywiak WH. Construct validation analyses on the Marlatt typology of relapse precipitants. Addiction 1996; 91 (suppl):S89-S97.
5. Stout RL, Longabaugh R, Rubin A. Predictive validity of Marlatt's relapse taxonomy versus a more general relapse code. Addiction 1996; 91 (suppl):S99-S110.
6. Zywiak WH, Connors GJ, Maisto SA, Westerberg VS. Relapse research and the Reasons for Drinking Questionnaire: a factor analysis of Marlatt's relapse taxonomy. Addiction 1996; 91 (suppl):S121-S130.
7. Carroll KM. Relapse prevention as a psychosocial treatment: a review of controlled clinical trials. Exp Clin Psychopharmacol 1996; 4:46-54. This is a comprehensive review of more than 24 randomized controlled trials that have evaluated the effectiveness of cognitive-behavioral relapse prevention treatment in substance use disorders.
8. Ouimette PC, Finney JW, Moos RH. Twelve-step and cognitive-behavioral treatment for substance abuse: a comparison of treatment effectiveness. J Consult Clin Psychol 1997; 65:230-240.
9. Allsop S, Saunders B, Phillips M, Carr A. A trial of relapse prevention with severely dependent male problem drinkers. Addiction 1997; 92:61-73.
10. Donovan M, Heather N. Acceptability of the controlled-drinking goal among alcohol treatment agencies in New South Wales. Australia. J Stud Alcohol 1997; 58:253-256.
11. Kavanagh DJ, Sitharthan T, Sayer GP. Prediction of results from correspondence treatment for controlled drinking. Addiction 1996; 91:1539-1545.
12. Iguchi MY, Belding MA, Morral AR, Lamb RJ, Husband SD. Reinforcing operants other than abstinence in drug abuse treatment: an effective alternative for reducing drug use. J Consult Clin Psychol 1997; 65:421-428. The authors test an incentive-based therapy that diverges significantly from those tested previously. Vouchers were used in a methadone maintenance program to shape behaviors consistent with long-term treatment plan goals.
13. Schmitz JM, Rhoades H, Elk R, Creson D, Grabowski J. Medication take home doses and contingency management. Exp Clin Psychopharmacol (in press).
14. Fals-Stewart W, Birchler GR, O'Farrell TJ. Behavioral couples therapy for male substance-abusing patients: effects on relationship adjustment and drug-using behavior. J Consult Clin Psychol 1996; 64:959-972.
15. Bachmann KM, Moggi F, Hirsbrunner HP, Donati R, Brodbeck J. An integrated treatment program for dually diagnosed patients. J Psychiatr Serv 1997; 48:314-316.
16. Ferman J. Gold award: integrated mental health and substance abuse services to at-risk families. Psychiatr Serv 1996; 47:1112-1114.
17. Alterman AI, Rutherford MJ, Cacciola JS, McKay JR, Woody GE. Response to methadone maintenance and counseling in antisocial patients with and without major depression. J Nerv Ment Dis 1996; 184:695-702.
18. Fisher MS, Bentley KJ. Two group therapy models for clients with a dual diagnosis of substance abuse and personality disorder. Psychiatr Serv 1996:47:1244-1250.
19. Allen JP, Mattson ME, Miller WR, Tonigan JS, Connors GJ, Rychtarik RG, et al. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol 1997; 58:7-29. This is one of the largest multisite clinical trials to date designed to test the 'matching hypothesis' that alcohol treatment effectiveness can be improved by assigning clients with certain characteristics to particular treatments that address those characteristics.
20. Jaffe AJ, Rounsaville B, Chang G, Schottenfeld RS, Meyer RE, O'Malley SS. Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching. J Consult Clin Psychol 1996; 64:1044-1053. This is the first research study to examine adequately patient-treatment matching effects for pharmacotherapy-psychotherapy interventions.
21. Finney JW, Hahn AC, Moos RH. The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects. Addiction 1996: 91:1773-1796. The authors provide an updated review of the relative effectiveness of inpatient and outpatient settings for treating alcohol abuse. Based on their sophisticated analysis of the data, they conclude that under some circumstances an inpatient treatment setting is more effective than an outpatient setting. Thus, the important question becomes under what set of circumstances will what variables in the inpatient setting mediate enhanced effectiveness?
22. McCusker J, Stoddard A, Frost R, Zorn M. Planned versus actual duration of drug abuse treatment-reconciling observational and experimental evidence. J Nerv Ment Dis 1996; 184:482-489.
23. Rhoades HM, Creson D, Elk R, Schmitz JM, Grabowski J. Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. Am J Public Health 1998; 88:34-39.
24. Grabowski J, Rhoades H, Elk R, Schmitz J, Davis C, Creson D, Kirby K. Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo controlled double-blind trials. J Clin Psychopharmacol 1995; 15:163-174.
25. O'Malley SS, Carroll KM. Psychotherapeutic considerations in pharmacological trials. Alcohol Clin Exp Res 1996; 20:17A-22A.